Junji Kawada

944 total citations
56 papers, 387 citations indexed

About

Junji Kawada is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Junji Kawada has authored 56 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 24 papers in Surgery and 22 papers in Oncology. Recurrent topics in Junji Kawada's work include Gastric Cancer Management and Outcomes (36 papers), Metastasis and carcinoma case studies (16 papers) and Gastrointestinal Tumor Research and Treatment (12 papers). Junji Kawada is often cited by papers focused on Gastric Cancer Management and Outcomes (36 papers), Metastasis and carcinoma case studies (16 papers) and Gastrointestinal Tumor Research and Treatment (12 papers). Junji Kawada collaborates with scholars based in Japan and China. Junji Kawada's co-authors include Hiroshi Imamura, Toshimasa Tsujinaka, Kazuhiro Nishikawa, Toshio Shimokawa, Yoshiyuki Fujiwara, Yutaka Kimura, Ryohei Kawabata, Jin Matsuyama, Yukinori Kurokawa and Yusuke Akamaru and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

Junji Kawada

46 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junji Kawada Japan 10 241 202 119 95 72 56 387
Keiichi Fujiya Japan 12 348 1.4× 247 1.2× 121 1.0× 87 0.9× 129 1.8× 53 494
L. Carbone Italy 10 120 0.5× 134 0.7× 87 0.7× 41 0.4× 38 0.5× 32 275
Masami Yuda Japan 15 291 1.2× 384 1.9× 88 0.7× 57 0.6× 21 0.3× 52 483
T Jastrzebski Poland 8 77 0.3× 165 0.8× 68 0.6× 82 0.9× 33 0.5× 33 295
Hirohito Fujikawa Japan 16 525 2.2× 410 2.0× 235 2.0× 248 2.6× 139 1.9× 54 780
Simon Kuesters Germany 17 180 0.7× 520 2.6× 190 1.6× 119 1.3× 121 1.7× 30 631
Yusuke Yamaoka Japan 14 149 0.6× 371 1.8× 400 3.4× 52 0.5× 23 0.3× 65 533
Young‐Gil Son South Korea 9 205 0.9× 185 0.9× 82 0.7× 29 0.3× 52 0.7× 20 301
Kazuhito Tsuchida Japan 14 531 2.2× 421 2.1× 198 1.7× 190 2.0× 134 1.9× 57 751
Jacopo Weindelmayer Italy 13 279 1.2× 350 1.7× 49 0.4× 42 0.4× 33 0.5× 41 401

Countries citing papers authored by Junji Kawada

Since Specialization
Citations

This map shows the geographic impact of Junji Kawada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Kawada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Kawada more than expected).

Fields of papers citing papers by Junji Kawada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Kawada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Kawada. The network helps show where Junji Kawada may publish in the future.

Co-authorship network of co-authors of Junji Kawada

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Kawada. A scholar is included among the top collaborators of Junji Kawada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Kawada. Junji Kawada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawabata, Ryohei, Kazuhiro Nishikawa, Junji Kawada, et al.. (2025). Multicenter phase II study on the efficacy of an oral nutritional supplement containing eicosapentaenoic acid in advanced gastric cancer patients with cachexia. Gastric Cancer. 28(4). 641–651. 1 indexed citations
2.
Fujitani, Kazumasa, Yukinori Kurokawa, Atsushi Takeno, et al.. (2024). Prospective single-arm multicenter interventional study of surgical resection for liver metastasis from gastric cancer; 3-year overall and recurrence-free survival. European Journal of Cancer. 213. 115080–115080. 3 indexed citations
3.
Nishikawa, Kazuhiro, Yutaka Kimura, Kentaro Kishi, et al.. (2024). Effects of postoperative oral elemental nutritional supplement on skeletal muscle loss after gastrectomy for gastric cancer. International Journal of Clinical Oncology. 29(3). 266–275. 1 indexed citations
4.
Kawada, Junji, Takuro Saito, Yukinori Kurokawa, et al.. (2023). Serum NY‐ESO‐1 and p53 antibodies as useful tumor markers in gastric cancer. Annals of Gastroenterological Surgery. 8(2). 243–250. 2 indexed citations
7.
Kawada, Junji, Shigeyuki Tamura, & Yo Sasaki. (2022). P41-5 A case of advanced gastric cancer treated successfully with nivolumab. Annals of Oncology. 33. S529–S529.
8.
Endo, Shunji, Kazuhiro Nishikawa, Masakazu Ikenaga, et al.. (2021). Prognostic factors for cytology-positive gastric cancer: a multicenter retrospective analysis. International Journal of Clinical Oncology. 26(5). 858–866. 8 indexed citations
9.
Yamamoto, Sachiko, Hisato Kawakami, Hiroki Hara, et al.. (2021). Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201. European Journal of Cancer. 154. 307–315. 8 indexed citations
10.
Tamura, Shigeyuki, Hirokazu Taniguchi, Kazuhiro Nishikawa, et al.. (2020). A phase II trial of dose-reduced nab-paclitaxel for patients with previously treated, advanced or recurrent gastric cancer (OGSG 1302). International Journal of Clinical Oncology. 25(12). 2035–2043. 4 indexed citations
12.
Endo, Shunji, Yoshinori Fujiwara, Tomoki Yamatsuji, et al.. (2020). Is it Necessary to Confirm Negative Margins in Gastrectomy for Peritoneal Lavage Cytology-positive Gastric Cancer?. Anticancer Research. 40(10). 5807–5813. 2 indexed citations
13.
Ogino, Takayuki, Junji Kawada, Miho Okano, et al.. (2019). The Risk Factor of Anastomotic Hypoperfusion in Colorectal Surgery. Journal of Surgical Research. 244. 265–271. 13 indexed citations
14.
Kawada, Junji, Masaya Nishino, Yoshinori Hayashi, et al.. (2019). [A Case of Esophageal Cancer with Aortic Thrombosis That Was Successfully Treated by Aortic Thrombectomy and Video-Assisted Thoracoscopic Esophagectomy].. PubMed. 46(2). 366–368.
16.
Wada, Noriko, Tsuyoshi Takahashi, Yukinori Kurokawa, et al.. (2017). Appropriate Follow-Up Strategies for Gastrointestinal Stromal Tumor Patients Based on the Analysis of Recurrent Interval and Patterns. Digestion. 95(2). 115–121. 5 indexed citations
17.
Nishikawa, Kazuhiro, Chu Matsuda, Junji Kawada, et al.. (2016). [A Case of Rectal Metastasis of Gastric Cancer Associated with Dermatomyositis].. PubMed. 43(12). 2401–2403. 3 indexed citations
18.
Imamura, Hiroshi, Kazuhiro Nishikawa, Kentaro Kishi, et al.. (2016). Effects of an Oral Elemental Nutritional Supplement on Post-gastrectomy Body Weight Loss in Gastric Cancer Patients: A Randomized Controlled Clinical Trial. Annals of Surgical Oncology. 23(9). 2928–2935. 68 indexed citations
19.
Nishikawa, Kazuhiro, Hiroshi Imamura, Masahiro Gotoh, et al.. (2015). A randomized phase II factorial design trial of CPT-11 versus PTX versus each combination with S-1 in patients with advanced gastric cancer refractory to S-1: Final results of OGSG0701.. Journal of Clinical Oncology. 33(3_suppl). 117–117. 4 indexed citations
20.
Tsujinaka, Toshimasa, Kazuyoshi Yamamoto, Junya Fujita, et al.. (2013). Subcuticular sutures versus staples for skin closure after open gastrointestinal surgery: a phase 3, multicentre, open-label, randomised controlled trial. The Lancet. 382(9898). 1105–1112. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026